AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled amplicons
Authors: Ricevuto, E Sobol, H Stoppa-Lyonnet, D Gulino, A Marchetti, P Ficorella, C Martinotti, S Meo, T Tosi, M
Citation: E. Ricevuto et al., Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled amplicons, CLIN CANC R, 7(6), 2001, pp. 1638-1646
Color bar coding the BRCAI gene on combed DNA: A useful strategy for detecting large gene rearrangements
Authors: Gad, S Aurias, A Puget, N Mairal, A Schurra, C Montagna, M Pages, S Caux, V Mazoyer, S Bensimon, A Stoppa-Lyonnet, D
Citation: S. Gad et al., Color bar coding the BRCAI gene on combed DNA: A useful strategy for detecting large gene rearrangements, GENE CHROM, 31(1), 2001, pp. 75-84
Genome instability in secondary solid tumors developing after radiotherapyof bilateral retinoblastoma
Authors: Lefevre, SH Vogt, N Dutrillaux, AM Chauveinc, K Stoppa-Lyonnet, D Doz, F Desjardins, L Dutrillaux, B Chevillard, S Malfoy, B
Citation: Sh. Lefevre et al., Genome instability in secondary solid tumors developing after radiotherapyof bilateral retinoblastoma, ONCOGENE, 20(56), 2001, pp. 8092-8099
Colour bar coding on combed DNA revealed large gene rearrangements of BRCA1 gene
Authors: Gad, S Stoppa-Lyonnet, D Aurias, A Bensimon, A
Citation: S. Gad et al., Colour bar coding on combed DNA revealed large gene rearrangements of BRCA1 gene, M S-MED SCI, 17(10), 2001, pp. 1072-1075
Identification of a large rearrangement of the BRCA1 gene using colour barcode on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing
Authors: Gad, S Scheuner, MT Pages-Berhouet, S Caux-Moncoutier, V Bensimon, A Aurias, A Pinto, M Stoppa-Lyonnet, D
Citation: S. Gad et al., Identification of a large rearrangement of the BRCA1 gene using colour barcode on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing, J MED GENET, 38(6), 2001, pp. 388-392
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome
Authors: Bougeard, G Limacher, JM Martin, C Charbonnier, F Killian, A Delattre, O Longy, M Jonveaux, P Fricker, JP Stoppa-Lyonnet, D Flaman, JM Frebourg, T
Citation: G. Bougeard et al., Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome, J MED GENET, 38(4), 2001, pp. 253-256
Sensitivity and predictive value of criteria for p53 germline mutation screening
Authors: Chompret, A Abel, A Stoppa-Lyonnet, D Brugieres, L Pages, S Feunteun, J Bonaiti-Pellie, C
Citation: A. Chompret et al., Sensitivity and predictive value of criteria for p53 germline mutation screening, J MED GENET, 38(1), 2001, pp. 43-47
Cancer risk in heterozygotes for ataxia-telangiectasia
Authors: Geoffroy-Perez, B Janin, N Ossian, K Lauge, A Croquette, MF Griscelli, C Debre, M Bressac-De-Paillerets, B Aurias, A Stoppa-Lyonnet, D Andrieu, N
Citation: B. Geoffroy-perez et al., Cancer risk in heterozygotes for ataxia-telangiectasia, INT J CANC, 93(2), 2001, pp. 288-293
Li-Fraumeni syndrome: update, new data and guidelines for clinical management
Authors: Frebourg, T Ebel, A Bonaiti-Pellie, C Brugieres, L Berthet, P Bressac-De Paillerets, B Chevrier, A Chompret, A Cohen-Haguenauer, O Delattre, O Feingold, J Feunteun, J Frappaz, D Fricker, JP Gesta, P Jonveaux, P Kalifa, C Lasset, C Leheup, B Limacher, JM Longy, M Nogues, C Oppenheim, D Sommelet, D Soubrier, F Stoll, C Stoppa-Lyonnet, D Tristant, H
Citation: T. Frebourg et al., Li-Fraumeni syndrome: update, new data and guidelines for clinical management, B CANCER, 88(6), 2001, pp. 581-587
Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons
Authors: Pages, S Caux, V Stoppa-Lyonnet, D Tosi, M
Citation: S. Pages et al., Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons, BR J CANC, 84(4), 2001, pp. 482-488
The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Familial invasive breast cancers: Worse outcome related to BRCA1 mutations
Authors: Stoppa-Lyonnet, D Ansquer, Y Dreyfus, H Gautier, C Gauthier-Villars, M Bourstyn, E Clough, KB Magdelenat, H Pouillart, P Vincent-Salomon, A Fourquet, A Asselain, B
Citation: D. Stoppa-lyonnet et al., Familial invasive breast cancers: Worse outcome related to BRCA1 mutations, J CL ONCOL, 18(24), 2000, pp. 4053-4059
Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors
Authors: Julian-Reynier, C Eisinger, F Chabal, F Lasset, C Nogues, C Stoppa-Lyonnet, D Vennin, P Sobol, H
Citation: C. Julian-reynier et al., Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors, AM J MED G, 94(1), 2000, pp. 13-18
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
Authors: Narod, SA Brunet, JS Ghadirian, P Robson, M Heimdal, K Neuhausen, SL Stoppa-Lyonnet, D Lerman, C Pasini, B de los Rios, P Weber, B Lynch, H
Citation: Sa. Narod et al., Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study, LANCET, 356(9245), 2000, pp. 1876-1881
Acceptability of prophylactic mastectomy in cancer-prone women
Authors: Eisinger, F Julian-Reynier, C Stoppa-Lyonnet, D Lasset, C Nogues, C
Citation: F. Eisinger et al., Acceptability of prophylactic mastectomy in cancer-prone women, J AM MED A, 283(2), 2000, pp. 202-203
A survey of the current clinical facilities for the management of familialcancer in Europe
Authors: Hodgson, SV Haites, NE Caligo, M Chang-Claude, J Eccles, D Evans, G Moller, P Morrison, P Steel, CM Stoppa-Lyonnet, D Vasen, H
Citation: Sv. Hodgson et al., A survey of the current clinical facilities for the management of familialcancer in Europe, J MED GENET, 37(8), 2000, pp. 605-607
Role of the ATM gene in genetic predisposition to cancer
Authors: Bay, JO Uhrhammer, N Stoppa-Lyonnet, D Hall, J
Citation: Jo. Bay et al., Role of the ATM gene in genetic predisposition to cancer, B CANCER, 87(1), 2000, pp. 29-34
Low expression of bcl-2 in Brca1-associated breast cancers
Authors: Freneaux, P Stoppa-Lyonnet, D Mouret, E Kambouchner, M Nicolas, A Zafrani, B Vincent-Salomon, A Fourquet, A Magdelenat, H Sastre-Garau, X
Citation: P. Freneaux et al., Low expression of bcl-2 in Brca1-associated breast cancers, BR J CANC, 83(10), 2000, pp. 1318-1322
Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16(INK4A), P14(ARF) or cdk4 genes
Authors: Soufir, N Bressac-de Paillerets, B Desjardins, L Levy, C Bombled, J Gorin, I Schlienger, P Stoppa-Lyonnet, D
Citation: N. Soufir et al., Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16(INK4A), P14(ARF) or cdk4 genes, BR J CANC, 82(4), 2000, pp. 818-822
No germline ATM mutation in a series of 16 T-cell prolymphocytic leukemias
Authors: Stoppa-Lyonnet, D Lauge, A Sigaux, F Stern, MH
Citation: D. Stoppa-lyonnet et al., No germline ATM mutation in a series of 16 T-cell prolymphocytic leukemias, BLOOD, 96(1), 2000, pp. 374-376
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations
Authors: Wagner, T Stoppa-Lyonnet, D Fleischmann, E Muhr, D Pages, S Sandberg, T Caux, V Moeslinger, R Langbauer, G Borg, A Oefner, P
Citation: T. Wagner et al., Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations, GENOMICS, 62(3), 1999, pp. 369-376
ATM functions and ataxia-telangectasia phenotypes
Authors: Bay, JO Uhrhammer, N Hall, J Stoppa-Lyonnet, D Bignon, YJ
Citation: Jo. Bay et al., ATM functions and ataxia-telangectasia phenotypes, M S-MED SCI, 15(10), 1999, pp. 1086-1095
Cancer genetics services in Europe
Authors: Hodgson, S Milner, B Brown, I Bevilacqua, G Chang-Claude, J Eccles, D Evans, G Gregory, H Moller, P Morrison, P Steel, M Stoppa-Lyonnet, D Vasen, H Haites, N
Citation: S. Hodgson et al., Cancer genetics services in Europe, DIS MARKER, 15(1-3), 1999, pp. 3-13
Four years analysis of cancer genetic clinics activity in France from 1994to 1997: A survey on 801 patients
Authors: Sobol, H Bignon, YJ Bonaiti, C Cuisenier, J Lasset, C Lortholary, A Nogues, C Stoppa-Lyonnet, D Eisinger, F
Citation: H. Sobol et al., Four years analysis of cancer genetic clinics activity in France from 1994to 1997: A survey on 801 patients, DIS MARKER, 15(1-3), 1999, pp. 15-29
Risultati: 1-25 | 26-44